Primary record
2-Propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-
- 库存
- 8,425 克
- 纯度
- 98.1 %
- CAS
- 1707289-21-1
化合物标识与属性
- CAS
- 1707289-21-1
- PubChem CID
- 91885617
- SMILES
- COC1=CC(=C(C(=C1Cl)C2=CC3=CN=C(N=C3C=C2)N[C@@H]4COCC[C@@H]4NC(=O)C=C)Cl)OC
- Canonical SMILES
- C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1
名称与同义词
- Fisogatinib
- BLU-554
- fisogatinibum
- 1707289-21-1
- BLU554
- Fisogatinib [INN]
- Fisogatinib [USAN]
- BLU554(Fisogatinib)
- BLU554(Fisogatinib)?
- RefChem:921622
- 5Q7R99CKV2
- Fisogatinib (USAN/INN)
- Fisogatinib [USAN:INN]
- BLU111362
- Fisogatinib (BLU-554)
- C24H24Cl2N4O4
- UNII-5Q7R99CKV2
- FISOGATINIB [WHO-DD]
- BLU-111362
- BLU 554
- MFCD30496704
- N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide
- orb1304186
- BLU 554 [WHO-DD]
- CHEMBL4514636
- SCHEMBL16668287
- GTPL10220
- EX-A841
- CS3008
- MGZKYOAQVGSSGC-DLBZAZTESA-N
- GLXC-10936
- AMY16699
- CS-3008
- X439161
- BDBM50575072
- NSC795718
- s8503
- WHO 10947
- AKOS030632994
- ACN-037513
- CCG-269714
- CS 3008
- CS-5986
- NSC-795718
- X-439161
- AC-29871
- AS-55934
- BB160379
- DA-71570
- HY-100492
- J3.793.352J
- D11737
- A901394
- Q29209801
- Fibroblast Growth Factor Receptor 4 Inhibitor BLU-554
- B0084-008122
- 2-Propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-
- N-[(3S,4S)-3-{[6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino}oxan-4-yl]prop-2-enamide
- N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide
- N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxy-phenyl)quinazolin-2-yl]amino]tetrahydropyran-4-yl]prop-2-enamide
- N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino]tetrahydro-2H-pyran-4-yl]-2-propenamide
- N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]oxan-4-yl]prop-2-enamide